C. Frank Bennett, EVP, Chief Scientific Officer at IONIS PHARMACEUTICALS INC (IONS), sold 45,224 shares at $49.21 ($2.2M) on 2023-12-14, disclosed to the SEC on 2023-12-18.
Scheduled sale ($2.2M) by EVP, Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.21 | 14,002 | $689K | 30.7% |
| 2 | $49.21 | 14,002 | $689K | 30.7% |
| 3 | $50.19 | 8,610 | $432K | 19.3% |
| 4 | $50.19 | 8,610 | $432K | 19.3% |
| Total | $49.58 avg | 45,224 | $2.2M | 100% |
| Filing → |
| IONS | SELL | 2026-02-04 | $14.1M | — | Filing → |
| IONS | SELL | 2026-02-02 | $976K | — | Filing → |
| IONS | SELL | 2026-01-20 | $675K | — | Filing → |